Stay Alert for Safety Issues With Janus Kinase Inhibitors (Xeljanz, etc)

October 2019

Questions will pop up about the safety of Janus kinase (JAK) inhibitors....

Exclusive Subscriber Content

Best in class medication learning
Concise recommendations
Hundreds of practical resources

Subscribe Now Learn More

Login to access this content.

Login

Table of Contents

E-Cigarettes Emphasize Risks of Vaping and Help Kids and Teens Stop
Influenza Share the Latest Advice About 2019-2020 Influenza Immunizations
Practice Demystify the Ins and Outs of Compression Stockings
Anticoagulants Be Prepared to Manage Direct Oral Anticoagulants Around Surgery
Pediatrics Weigh Options for Managing Type 2 Diabetes in Kids
Contraceptives Don't Jump to the New Progestin-Only Oral Contraceptive, Slynd (Drospirenone)
Immunosuppressives Stay Alert for Safety Issues With Janus Kinase Inhibitors (Xeljanz, etc)
Vaccines Know When to Discuss HPV Vaccination With Adults Over Age 26
Antibiotics Save the Antibiotic Xenleta as a Last Resort
Medicare Be Familiar With Changes Coming to Medicare Part D in 2020
Irritable Bowel Syndrome Watch for Zelnorm's Return for Irritable Bowel Syndrome With Constipation
Fungal Infections Avoid Empiric Fluconazole for Candida auris